Oral Arguments Held In Dispute Over Controlled Release Budesonide Tablet
Mealey's (January 11, 2019, 1:18 PM EST) -- WASHINGTON, D.C. — An appeal of a Delaware federal judge’s determination that a patented pharmaceutical tablet with a core composed of a “macroscopically homogenous composition” for controlling the release of budesonide...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login